Global Natamycin Market Growth 2023-2029

Global Natamycin Market Growth 2023-2029

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

LPI (LP Information)' newest research report, the “Natamycin Industry Forecast” looks at past sales and reviews total world Natamycin sales in 2022, providing a comprehensive analysis by region and market sector of projected Natamycin sales for 2023 through 2029. With Natamycin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natamycin industry.

This Insight Report provides a comprehensive analysis of the global Natamycin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natamycin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Natamycin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natamycin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natamycin.

The global Natamycin market size is projected to grow from US$ 182 million in 2022 to US$ 285.4 million in 2029; it is expected to grow at a CAGR of 285.4 from 2023 to 2029.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Natamycin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Glucose-based

Lactose-based

Sodium chloride-based

Segmentation by application

Food

Medical

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Danisco

DSM

VGP

Handary

AMTECH BIOTECH

Silver-Elephant

Lanzhou Weiri

Langfang Meihua

Zhengzhou New Frey

Chihon

Jiaozuo Joincare

Beijing Oriental Rada

Pucheng Lifecome

Key Questions Addressed in this Report

What is the 10-year outlook for the global Natamycin market?

What factors are driving Natamycin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Natamycin market opportunities vary by end market size?

How does Natamycin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.